Zimmer Operating Margin from 2010 to 2024
| ZBH Stock | USD 110.96 0.74 0.67% |
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 999.3 M, Interest Expense of 141.5 M or Selling General Administrative of 2 B, as well as many indicators such as Price To Sales Ratio of 4.51, Dividend Yield of 0.0157 or PTB Ratio of 1.93. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
Zimmer | Operating Margin |
Latest Zimmer Biomet's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Zimmer Biomet Holdings over the last few years. It is Zimmer Biomet's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.18 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Zimmer Operating Margin Regression Statistics
| Arithmetic Mean | 0.16 | |
| Geometric Mean | 0.12 | |
| Coefficient Of Variation | 46.83 | |
| Mean Deviation | 0.06 | |
| Median | 0.15 | |
| Standard Deviation | 0.07 | |
| Sample Variance | 0.01 | |
| Range | 0.2408 | |
| R-Value | (0.35) | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.12 | |
| Significance | 0.20 | |
| Slope | (0.01) | |
| Total Sum of Squares | 0.07 |
Zimmer Operating Margin History
About Zimmer Biomet Financial Statements
Investors use fundamental indicators, such as Zimmer Biomet's Operating Margin, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. Zimmer Biomet operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 19500 people.
Currently Active Assets on Macroaxis
When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:Check out the analysis of Zimmer Biomet Correlation against competitors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.597 | Dividend Share 0.96 | Earnings Share 5.24 | Revenue Per Share 37.006 | Quarterly Revenue Growth 0.04 |
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.